IAVI RECEIVES GSK FUNDING FOR THE HUMAN VACCINES PROJECT TO ACCELERATE DEVELOPMENT OF VACCINES FOR INFECTIOUS DISEASES AND CANCER

IAVI Watch [14 February 2015]
http://www.iavi.org/press-releases/2015

IAVI RECEIVES GSK FUNDING FOR THE HUMAN VACCINES PROJECT TO ACCELERATE DEVELOPMENT OF VACCINES FOR INFECTIOUS DISEASES AND CANCER
February 13, 2015
NEW YORK – The International AIDS Vaccine Initiative (IAVI) has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project, a new public-private partnership seeking to transform global disease prevention by collaboratively addressing some of the principal scientific problems impeding vaccine development across diseases.

The GSK grant will help to establish the Project’s global consortium and plan its research program. The funding builds on a grant last year to IAVI by the Robert Wood Johnson Foundation for a series of workshops to explore how to accelerate development of vaccines via a Human Vaccines Project, by tackling the major scientific challenges impeding vaccine R&D through greater collaboration, increased knowledge sharing, and innovation. The first workshop, held in February 2014, focused on the scientific challenges to vaccine development, at which leading vaccine experts endorsed the Project’s objectives and helped to frame its scientific plan.

Wayne C. Koff, IAVI Chief Scientific Officer and founding member of the Human Vaccines Project Board, announced the GSK grant during a symposium at the AAAS 2015 Annual Meeting in San Jose, CA…